Transcept Pharma (TSPT) Swings to Q4 Profit of 37c/Share
Get Alerts TSPT Hot Sheet
Join SI Premium – FREE
Transcept Pharmaceuticals, Inc. (NASDAQ: TSPT) reported Q4 EPS of $0.37, versus ($0.20) reported last year. Revenue for the quarter came in at $12.8 million, versus $3.13 million reported last year.
For earnings history and earnings-related data on Transcept Pharmaceuticals, Inc. (TSPT) click here.
For earnings history and earnings-related data on Transcept Pharmaceuticals, Inc. (TSPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Diana Shipping withdraws bid to acquire Genco Shipping
- Diana Shipping drops bid for Genco after price demands spike to $36.91
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share